Specifically, higher STXBP1 expression correlated with significantly worse prognosis (log-rank P < 0.001), and no recurrence events were observed in the lower STXBP1 expression group in SCLC (Fig. 5F). Here, STXBP1 is linked to small cell lung carcinoma.